Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of treatments for human disease. The Company's drug programs include Sotagliflozin and LX9211. The Company also has a number of... Read more
CNBC
CNBC
MarketWatch
MarketWatch
Access detailed stock analysis from LSEG including analyst price target estimates.